Macitentan in Pulmonary Arterial Hypertension Due to Congenital Heart Disease (CHD-PAH): Real-World Evidence from the OPUS/OrPHeUS Studies

By sjmartinez • November 26, 2024

Chin KM, Channick R, Kim NH, Ong R, Turricchia S, Martin N, Mitchell L, McLaughlin VV. Macitentan in Pulmonary Arterial Hypertension Due to Congenital Heart Disease (CHD-PAH): Real-World Evidence from the OPUS/OrPHeUS Studies. Cardiol Ther. 2024 Nov 25. doi: 10.1007/s40119-024-00386-1. Epub ahead of print. PMID: 39585521.

Tags: congenital heart disease, Macitentan, Publications, pulmonary arterial hypertension, Pulmonary, Critical Care & Sleep Medicine, real-world evidence

The Family Perspectives Project: development and preliminary feasibility of a chaplain-delivered emotional support intervention for families of critically ill patients

Modes ME, Kross EK, Duru OK, Sherman A, Ahluwalia SC, Walling AM, Lazor P, Nuckols TK. The Family Perspectives Project: development and preliminary feasibility of[...]

Regional heterogeneity and sex differences along the mouse aorta

Sveeggen TM, Kosmach A, Mitchell R, Brockmann BC, Meisinger TM, Stratman AN, Mack JJ, Cook JR, Bagher P. Regional heterogeneity and sex differences along the[...]

Cost Offset With Quadruple Therapy for Heart Failure

Keykhaei M, Rashedi S, Greene SJ, Yancy C, Ziaeian B, Sandhu AT, Kittleson M, Fonarow GC. Cost Offset With Quadruple Therapy for Heart Failure. JAMA[...]